| |
|
INDUSTRIAL
INVESTMENT
Midpharma is Public Shareholding Company
founded in 1993 and commenced production by the end of 1997. Midpharma
currently produces Antibiotics, Analgesics-Antipyretics, Vitamins, Haematinics,
Cardiovascular preparations, Hypoglycemics, Antiulcerants, and Antifungals.
In 2005, Midpharma has acquired new
product lines consisting of deramatologicals, local analgesics, topical nasal
decongestants, topical anti-hemorrhoidals, gynaecological anti-infectives, and
laxatives.
Midpharma’s production site is spread
over 35,000 m2 consisting of a general plant and a cephalosporin’s plant with
production lines consisting of tablet, capsule, aerosol, suppository, ointment,
liquid, dry-suspension, and counting. Midpharma holds European Good
Manufacturing Practice (GMP) for solid dosage form in general formulation as
well as Jordanian GMP for both plants. We are also ISO9001:2000 certified.
Midpharma’s manufacturing strengths made
it a world-class producer of branded generics. Midpharma’s products are
registered and actively sold in all the major Middle East and North African
markets.
Midpharma differentiates itself by
successfully managing profitable growth whilst maintaining customer
responsiveness. The leadership and staff are totally committed to quality and
are continually on the look out for further development.
Top |
|
